Status:
UNKNOWN
"Impact of Pelvic Floor Prehabilitation Using Biofeedback on the Severity of the Low Anterior Resection Syndrome in Patients Undergoing a Total Mesorectal Excision for Rectal Cancer"
Lead Sponsor:
Nantes University Hospital
Conditions:
Rectal Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
There is currently no specific treatment and only few measures to prevent the low anterior resection syndrome (LARS). The LARS often results in a severe alteration of quality of life. This study is de...
Eligibility Criteria
Inclusion
- Age between 18 and 80 years old
- Total mesorectal excision with colorectal or coloanal anastomosis protected by an ileostomy or a colostomy for rectal cancer
- Absence of anastomotic leakage or stenosis
- Informed consent to participate in the study
- Social security insurance affiliation
Exclusion
- History of anal incontinence and/or fecal urgency and/or chronic diarrhea requiring a specific treatment before rectal cancer management
- Absence of ileostomy or colostomy
- Anastomotic leakage
- Sensorial or cognitive disorders impeding pelvic floor rehabilitation exercise
- Pregnant women
- Minors
- Adults under guardianship
Key Trial Info
Start Date :
May 27 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT03876561
Start Date
May 27 2019
End Date
May 1 2022
Last Update
April 3 2020
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Angers
Angers, France
2
APHP-Hôpital Beaujon
Clichy, France
3
CHD Vendée
La Roche-sur-Yon, France
4
Clinic Jules Verne
Nantes, France